BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25308402)

  • 1. Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population.
    Di Taranto MD; Staiano A; D'Agostino MN; D'Angelo A; Bloise E; Morgante A; Marotta G; Gentile M; Rubba P; Fortunato G
    Mol Cell Probes; 2015 Feb; 29(1):19-24. PubMed ID: 25308402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
    van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
    Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis.
    Laurila PP; Naukkarinen J; Kristiansson K; Ripatti S; Kauttu T; Silander K; Salomaa V; Perola M; Karhunen PJ; Barter PJ; Ehnholm C; Peltonen L
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):346-52. PubMed ID: 19910639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease.
    Lee JC; Weissglas-Volkov D; Kyttälä M; Sinsheimer JS; Jokiaho A; de Bruin TW; Lusis AJ; Brennan ML; van Greevenbroek MM; van der Kallen CJ; Hazen SL; Pajukanta P
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2222-7. PubMed ID: 17673701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of upstream stimulatory factor 1 gene variant in familial combined hyperlipidemia and related disorders.
    Auer S; Hahne P; Soyal SM; Felder T; Miller K; Paulmichl M; Krempler F; Oberkofler H; Patsch W
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1535-44. PubMed ID: 22460558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia.
    De Castro-Orós I; Cenarro A; Tejedor MT; Baila-Rueda L; Mateo-Gallego R; Lamiquiz-Moneo I; Pocoví M; Civeira F
    Circ Cardiovasc Genet; 2014 Dec; 7(6):814-21. PubMed ID: 25176936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
    Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
    Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia.
    van der Vleuten GM; Isaacs A; Hijmans A; van Duijn CM; Stalenhoef AF; de Graaf J
    J Lipid Res; 2007 Jan; 48(1):193-200. PubMed ID: 17065663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome.
    Singmann P; Baumert J; Herder C; Meisinger C; Holzapfel C; Klopp N; Wichmann HE; Klingenspor M; Rathmann W; Illig T; Grallert H
    Obes Facts; 2009; 2(4):235-42. PubMed ID: 20054229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemia.
    Hu M; Mak VW; Tomlinson B
    J Clin Lipidol; 2012; 6(6):585-92. PubMed ID: 23312054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction.
    De Caterina R; Talmud PJ; Merlini PA; Foco L; Pastorino R; Altshuler D; Mauri F; Peyvandi F; Lina D; Kathiresan S; Bernardinelli L; Ardissino D;
    Atherosclerosis; 2011 Feb; 214(2):397-403. PubMed ID: 21130994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.
    Chandak GR; Ward KJ; Yajnik CS; Pandit AN; Bavdekar A; Joglekar CV; Fall CH; Mohankrishna P; Wilkin TJ; Metcalf BS; Weedon MN; Frayling TM; Hattersley AT
    BMC Med Genet; 2006 Oct; 7():76. PubMed ID: 17032446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common polymorphisms in the USF1 gene are not associated with type 2 diabetes in French Caucasians.
    Gibson F; Hercberg S; Froguel P
    Diabetes; 2005 Oct; 54(10):3040-2. PubMed ID: 16186412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.
    Liu ZK; Hu M; Baum L; Thomas GN; Tomlinson B
    Atherosclerosis; 2010 Feb; 208(2):427-32. PubMed ID: 19732897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
    Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
    Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
    Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P
    BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.
    Plaisier CL; Horvath S; Huertas-Vazquez A; Cruz-Bautista I; Herrera MF; Tusie-Luna T; Aguilar-Salinas C; Pajukanta P
    PLoS Genet; 2009 Sep; 5(9):e1000642. PubMed ID: 19750004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.
    Coon H; Xin Y; Hopkins PN; Cawthon RM; Hasstedt SJ; Hunt SC
    Hum Genet; 2005 Sep; 117(5):444-51. PubMed ID: 15959806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
    Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
    Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of APOA5 variants on plasma triglyceride levels in Uyghur population.
    Li S; Hu B; Wang Y; Wu D; Jin L; Wang X
    PLoS One; 2014; 9(10):e110258. PubMed ID: 25313938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.